Placeholder Banner

BIO Congratulates Alex Azar on Confirmation as Secretary of Health and Human Services

January 24, 2018

Washington, DC (January 24, 2018) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the confirmation of Alex Azar as United States Secretary of Health and Human Services (HHS):

“We look forward to working with Mr. Azar as he tackles the many pressing issues within the American health care system. I am confident that American patients will be well served by his leadership and I congratulate him on his confirmation.

“The opportunities facing HHS today are enormous. From encouraging the development of new technologies to help solve the opioid crisis and removing barriers to value-based payment models, to overseeing the FDA and NIH as they implement landmark new legislation to speed the science and development of new cures and promote greater competition and choice in the marketplace, the decisions made at HHS today will leave a lasting imprint on American health care for decades to come.”

 

Upcoming BIO Events

BIO CEO & Investor Conference
February 12-13, 2018
New York, New York

BIO Asia International Conference
March 19-20, 2018
Tokyo, Japan

BIO International Convention
June 4-7, 2018
Boston, MA

 

###

Discover More
Washington, D.C. (September 1, 2020) – A U.S. regulatory system that keeps pace with science will put much-needed tools into the hands of farmers, help combat climate change, and advance sustainable farming practices, according to the Biotechnology…
  Today, Inova Software and the Biotechnology Innovation Organization (BIO) are announcing the first international series of virtual partnering events focused on three critical therapeutic areas with great unmet need -  oncology,…
America’s position as an innovation leader is at stake  Washington, D.C. (August 19, 2020) – The U.S. government’s system for regulating animal biotechnology – currently under the U.S. Food and Drug Administration (FDA) – is broken and is…